SBRI offer £1 million grants to develop innovative technologies for cancer screening to facilitate earlier diagnosis

Published on 04 Aug 17, under Cancer, Science & Research

SBRI Healthcare have announced a new funding round focused on finding innovative approaches to cancer screening that facilitate earlier and faster diagnosis. Detecting cancer earlier can allow treatment in the initial stages of the disease. This is key for reducing deaths caused by the disease, which affects 1 in 2 people during their lifetimes.

Companies that apply successfully can receive up to £100,000 of funding for phase one (feasibility) and up to £1 million for phase two (development) for solutions that match the needs of the NHS.

SBRI Healthcare is an NHS England initiative led by the Academic Health Science Networks to develop technology solutions for known healthcare challenges.

The key dates are:

  • Deadline for applications: noon, 6th September 2017
  • Assessments: September-November 2017
  • Contracts awarded: Late November 2017

For more information, take a look at the SBRI HEALTHCARE WEBSITE

Breath Biopsy®

If you want to learn more about how Owlstone Medical's Breath Sampling and Analysis technology is being utilised in Early Detection Research why not check out our free ebook: Breath Biopsy: The Complete Guide?

Breath Biopsy Complete Guide

Owlstone  world-leading team provides a range of premium services for non-invasive diagnostics

Our expert team can support every step of your breath biomarker research from study design to data analysis

View our services